Keizo Yoshida

3.6k citations

121 papers · 2.9k indexed · h-index 30

Impact in

Biological Psychiatry top 1%
- Tryptophan and brain disorders
Pharmacology top 1%
- Treatment of Major Depression
- Microbial Natural Products and Biosynthesis

Papers in

Biological Psychiatry 17
- Tryptophan and brain disorders 17
Pharmacology 44
- Treatment of Major Depression 27
- Microbial Natural Products and Biosynthesis 7

Co-authors: Hisashi Higuchi Hitoshi Takahashi Tetsuo Shimizu Mitsuhiro Kamata Kazuyuki Inoue Kunihiko Itoh Norio Ozaki Yasuhiro Kita
Journals: The Journal of Antibiotics (15 papers)Clinical Neuropharmacology (9 papers)Human Psychopharmacology Clinical and Experimental (8 papers)Progress in Neuro-Psychopharmacology and Biological Psychiatry (7 papers)European Journal of Pharmacology (6 papers)
Partner nations: Japan United States Greece

In The Last Decade

Keizo Yoshida

120 papers receiving 2.8k citations

Peers

Countries citing papers authored by Keizo Yoshida

Since Specialization

Citations

This map shows the geographic impact of Keizo Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keizo Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keizo Yoshida more than expected).

Fields of papers citing papers by Keizo Yoshida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keizo Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keizo Yoshida. The network helps show where Keizo Yoshida may publish in the future.

Co-authors

The 25 scholars most cited alongside Keizo Yoshida, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Keizo Yoshida Line = papers co-authored together Keizo Yoshida links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Bcl1 Polymorphism of the Glucocorticoid Receptor Gene and Treatment Response to Milnacipran and Fluvoxamine in Japanese Patients with Depression Neuropsychobiology ·Hitoshi Takahashi, Keizo Yoshida, Hisashi Higuchi, Mitsuhiro Kamata, Kazuyuki Inoue, Toshio Suzuki, Jun Ishigooka	2014	5
2	Effectiveness of Milnacipran for the Treatment of Chronic Pain in the Orofacial Region Clinical Neuropharmacology ·Mikiko Ito, Hiroyuki Kimura, Keizo Yoshida, LUO Wei-duo, Norio Ozaki, Kenichi Kurita	2010	31
3	Augmentation with olanzapine in TCA‐refractory depression with melancholic features: a consecutive case series Human Psychopharmacology Clinical and Experimental ·Hitoshi Takahashi, Mitsuhiro Kamata, Keizo Yoshida, Hisashi Higuchi, Jun Ishigooka	2008	8
4	No Association of the G1287A Polymorphism in the Norepinephrine Transporter Gene and Susceptibility to Major Depressive Disorder in a Japanese Population Biological and Pharmaceutical Bulletin ·Kazuyuki Inoue, Kunihiko Itoh, Keizo Yoshida, Hisashi Higuchi, Mitsuhiro Kamata, Hitoshi Takahashi, Tetsuo Shimizu, Toshio Suzuki	2007	14
5	Successful Treatment of Trigeminal Neuralgia With Milnacipran Clinical Neuropharmacology ·Mikiko Ito, Keizo Yoshida, Hiroyuki Kimura, Norio Ozaki, Kenichi Kurita	2007	8
6	Response Rate Obtained Using Milnacipran Depending on the Severity of Depression in the Treatment of Major Depressive Patients Clinical Neuropharmacology ·Yuka Sugawara, Hisashi Higuchi, Keizo Yoshida, Hitoshi Takahashi, Mitsuhiro Kamata, 真弓佐久間, Kazuhiro Sato, Tetsuo Shimizu	2006	7
7	Switching to Olanzapine After Unsuccessful Treatment With Risperidone During the First Episode of Schizophrenia The Journal of Clinical Psychiatry ·Hitoshi Takahashi, Mitsuhiro Kamata, Keizo Yoshida, Jun Ishigooka, Hisashi Higuchi	2006	25
8	A three-factor model of the MADRS in major depressive disorder Depression and Anxiety ·Akihito Suzuki, Toshiaki Aoshima, Takashi Fukasawa, Keizo Yoshida, Hisashi Higuchi, Tetsuo Shimizu, Koichi Otani	2005	67
9	Hydroxyimine NO-Donors; FK409 and Derivatives Current Topics in Medicinal Chemistry ·Keizo Yoshida, Yasuhiro Kita	2005	6
10	Positive Association between <i>T-182C</i> Polymorphism in the Norepinephrine Transporter Gene and Susceptibility to Major Depressive Disorder in a Japanese Population Neuropsychobiology ·Kazuyuki Inoue, Kunihiko Itoh, Keizo Yoshida, Tetsuo Shimizu, Toshio Suzuki	2004	52
11	Prediction of Antidepressant Response to Milnacipran by Norepinephrine Transporter Gene Polymorphisms American Journal of Psychiatry ·Keizo Yoshida, Hitoshi Takahashi, Hisashi Higuchi, Mitsuhiro Kamata, Kenichi Ito, Kazuhiro Sato, 真弓佐久間, Tetsuo Shimizu, Kunihiko Itoh, Kazuyuki Inoue, Toshio Suzuki, Charles B. Nemeroff	2004	135
12	Milnacipran plasma levels and antidepressant response in Japanese major depressive patients Human Psychopharmacology Clinical and Experimental ·Hisashi Higuchi, Keizo Yoshida, Hitoshi Takahashi, 真弓佐久間, Mitsuhiro Kamata, Kenichi Ito, Kazuhiro Sato, A Carrus, Tetsuo Shimizu, Mamoru Nakanishi, Yasuo Hishikawa	2003	21
13	Association between -1438G/A Promoter Polymorphism in the 5-HT<sub>2A</sub> Receptor Gene and Fluvoxamine Response in Japanese Patients with Major Depressive Disorder Neuropsychobiology ·Kazuhiro Sato, Keizo Yoshida, Hitoshi Takahashi, Kenichi Ito, Mitsuhiro Kamata, Hisashi Higuchi, Tetsuo Shimizu, Kunihiko Itoh, Kazuyuki Inoue, Takehiko Tezuka, Toshio Suzuki, Tadashi Ohkubo, Kazunobu Sugawara, Koichi Otani	2002	63
14	Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Keizo Yoshida, Kenichi Ito, Kazuhiro Sato, Hitoshi Takahashi, Mitsuhiro Kamata, Hisashi Higuchi, Tetsuo Shimizu, Kunihiko Itoh, Kazuyuki Inoue, Takehiko Tezuka, Toshio Suzuki, Tadashi Ohkubo, Kazunobu Sugawara, Koichi Otani	2002	196
15	Enhancement of mycinamicin production by dotriacolide inMicromonospora griseorubida FEMS Microbiology Letters ·鎭馨金, Keizo Yoshida, 武則山下, Kentaro Shimizu, Sook Do Kwon, Kenji Kinoshita	1998	4
16	Comparison of antiplatelet effects of FK409, a spontaneous nitric oxide releaser, with those of TRK-100, a prostacyclin analogue European Journal of Pharmacology ·Yoshimi Hirasawa, Mie Nishio, Kazuhiro Maeda, Keizo Yoshida, Yasuhiro Kita	1995	14
17	The Neuroprotective Effect of the Novel Noncompetitive NMDA Antagonist, FR115427 in Focal Cerebral Ischemia in Rats Journal of Cerebral Blood Flow & Metabolism ·Kiyotaka Katsuta, Hajime Nakanishi, R. W. Strickling, Keizo Yoshida, Kiyoshi Takagi, Akira Tamura	1995	29
18	Effect of TFC-612, a 7-thia prostaglandin El derivative, on intimal thickening after endothelial injury with balloon catheter in rats Atherosclerosis ·Yukio Motoyama, Jiro Seki, Ting‐Yueh Lee, Mie Nishio, Keizo Yoshida	1994	6
19	FK409, a novel vasodilator isolated from the acid-treated fermentation broth of Streptomyces griseosporeus. I. Taxonomy, fermentation, isolation, and physico-chemical and biological characteristics. The Journal of Antibiotics ·Motohiro Hino, Morita Iwami, Masanori Okamoto, Keizo Yoshida, Benedict Hollingdale, MASAKUNI OKUHARA, JUNJI HOSODA, MASANOBU KOHSAKA, HATSUO AOKI, Hiroshi Imanaka	1989	60
20	Vinigrol, a novel antihypertensive and platelet aggregation inhibitory agent produced by a fungus, Virgaria nigra. II. Pharmacological characteristics. The Journal of Antibiotics ·Takeshi Ando, Keizo Yoshida, MASAKUNI OKUHARA	1988	49

About Keizo Yoshida

Keizo Yoshida is a scholar working on Biological Psychiatry, Pharmacology, Psychiatry and Mental health, Cellular and Molecular Neuroscience and Physiology, having authored 121 papers that have together received 2.9k indexed citations. Recurring topics across this work include Treatment of Major Depression (27 papers), Tryptophan and brain disorders (17 papers), Neurotransmitter Receptor Influence on Behavior (14 papers), Nitric Oxide and Endothelin Effects (12 papers), Bipolar Disorder and Treatment (12 papers), Schizophrenia research and treatment (10 papers), Microbial Natural Products and Biosynthesis (7 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (6 papers). The work is most often cited by research in Biological Psychiatry (301 citations), Pharmacology (773 citations), Psychiatry and Mental health (616 citations), Cellular and Molecular Neuroscience (593 citations) and Behavioral Neuroscience (110 citations). Keizo Yoshida has collaborated with scholars based in Japan, United States and Greece. Frequent co-authors include Hisashi Higuchi, Hitoshi Takahashi, Tetsuo Shimizu, Mitsuhiro Kamata, Kazuyuki Inoue, Kunihiko Itoh, Norio Ozaki, Yasuhiro Kita, Kazuhiro Sato and MASANOBU KOHSAKA. Their work appears in journals such as The Journal of Antibiotics, Clinical Neuropharmacology, Human Psychopharmacology Clinical and Experimental, Progress in Neuro-Psychopharmacology and Biological Psychiatry and European Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact